Toxicology of oncologic drugs. 1990

D A O'Keefe, and C L Harris
Department of Veterinary Clinical Medicine, University of Illinois, Urbana-Champaign College of Veterinary Medicine.

The drugs used in clinical oncology are inherently toxic because they are designed to kill host cells. For the most part, the toxic effects occur in tissues with high growth fractions--that is, bone marrow, gastrointestinal epithelium, and hair follicles. Nevertheless, certain drugs do cause harm to other organs. At therapeutic doses of anticancer drugs, the toxicoses are usually mild to moderate and can be managed without undue discomfort to the animal. Occasionally, however, life-threatening cytopenias occur. By contrast, with drug overdose, life-threatening toxicoses can be a very real concern.

UI MeSH Term Description Entries
D005767 Gastrointestinal Diseases Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Cholera Infantum,Gastrointestinal Disorders,Functional Gastrointestinal Disorders,Gastrointestinal Disorders, Functional,Disease, Gastrointestinal,Diseases, Gastrointestinal,Functional Gastrointestinal Disorder,Gastrointestinal Disease,Gastrointestinal Disorder,Gastrointestinal Disorder, Functional
D006402 Hematologic Diseases Disorders of the blood and blood forming tissues. Blood Diseases,Hematological Diseases,Blood Disease,Disease, Blood,Disease, Hematologic,Disease, Hematological,Diseases, Blood,Diseases, Hematologic,Diseases, Hematological,Hematologic Disease,Hematological Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

D A O'Keefe, and C L Harris
March 1977, National Cancer Institute monograph,
D A O'Keefe, and C L Harris
March 1990, The Veterinary clinics of North America. Small animal practice,
D A O'Keefe, and C L Harris
March 1990, The Veterinary clinics of North America. Small animal practice,
D A O'Keefe, and C L Harris
August 1952, Schweizerische medizinische Wochenschrift,
D A O'Keefe, and C L Harris
June 2004, Forensic science international,
D A O'Keefe, and C L Harris
October 1968, Archives of ophthalmology (Chicago, Ill. : 1960),
D A O'Keefe, and C L Harris
November 1969, Archives of ophthalmology (Chicago, Ill. : 1960),
D A O'Keefe, and C L Harris
March 1972, Chemistry in Britain,
D A O'Keefe, and C L Harris
October 2011, Clinical toxicology (Philadelphia, Pa.),
Copied contents to your clipboard!